Cancer Trials Ireland
- Country
- 🇮🇪Ireland
- Ownership
- Private
- Established
- 1996-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.cancertrials.ie
Clinical Trials
97
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (73 trials with phase data)• Click on a phase to view related trials
Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study
- Conditions
- Primary Peritoneal CarcinomaFallopian Tube CancerSerous Ovarian TumorEndometrioid Carcinoma Ovary
- First Posted Date
- 2024-02-23
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 200
- Registration Number
- NCT06274541
- Locations
- 🇮🇪
Mater Misericordiae University Hospital / Mater Private Hospital, Dublin, Leinster, Ireland
🇮🇪St James's Hospital, Dublin, Leinster, Ireland
🇮🇪Bon Secours, Cork, Munster, Ireland
Exploring the Impact of a Multi-modal Nutritional Intervention in Patients Undergoing Chemotherapy for Pancreatic Cancer (FEED Trial)
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2023-11-29
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 70
- Registration Number
- NCT06149546
- Locations
- 🇮🇪
St Vincent's University Hospital, Dublin, Leinster, Ireland
Spine SABR - Dose-escalated Stereotactic Ablative Body Radiotherapy (SABR) for Solid Tumour Spine Metastases
- Conditions
- Solid Tumor Spine Metastases
- First Posted Date
- 2023-10-12
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 126
- Registration Number
- NCT06078813
- Locations
- 🇮🇪
Bon Secours/UPMC, Cork, Ireland
🇮🇪St Luke's Radiation Oncology Network (SLRON) at Beaumont Hospital, Dublin, Ireland
🇮🇪Beacon Hospital, Dublin, Ireland
Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas)
- Conditions
- Pancreatic Adenocarcinoma
- First Posted Date
- 2023-09-06
- Last Posted Date
- 2025-07-20
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 49
- Registration Number
- NCT06024824
- Locations
- 🇮🇪
St Luke's Radiation Oncology Network (SLRON), Dublin, Ireland
🇮🇪St Vincent's University Hospital, Dublin, Ireland
Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-positive Breast Cancer (SHAMROCK Study)
- Conditions
- HER2-positive Breast Cancer
- Interventions
- First Posted Date
- 2023-02-02
- Last Posted Date
- 2024-08-05
- Lead Sponsor
- Cancer Trials Ireland
- Target Recruit Count
- 11
- Registration Number
- NCT05710666
- Locations
- 🇮🇪
University Hospital Galway, Galway, Connaught, Ireland
🇮🇪Saint Vincent's University Hospital, Dublin, Leinster, Ireland
🇮🇪Beaumont Hospital, Dublin, Leinster, Ireland
- Prev
- 1
- 2
- 3
- 4
- 5
- 14
- Next